Pharma Journalist 9001 posts 0 comments

Radiopharmaceuticals continue to reshape oncology strategy. Regeneron’s entry into radiopharma through its partnership with Telix investing $40M upfront across up to four oncology…
Read More...

MSD, known as Merck & Co., Inc. in the United States, has entered into a major multi-year partnership with Google Cloud aimed at transforming the pharmaceutical giant into a fully…
Read More...

AbbVie has announced a major $1.4 billion investment to establish a new pharmaceutical manufacturing campus in Durham, marking a significant expansion of its U.S. production…
Read More...

Clinical-stage biotech firm BioAegis Therapeutics has entered a strategic collaboration with Prenosis to accelerate the development of a precision medicine approach for inflammatory…
Read More...

The U.S. Food and Drug Administration has approved IDVYNSO, a new once-daily, single-tablet regimen developed by Merck, for the treatment of adults living with HIV-1. The therapy is…
Read More...

The U.S. Food and Drug Administration has approved an expanded indication for Tzield (teplizumab-mzwv), allowing its use in children as young as one year old to delay the onset of stage…
Read More...

Boehringer Ingelheim has announced a major expansion of its global Computational Innovation network with the launch of a new artificial intelligence (AI) and machine learning (ML)…
Read More...

The U.S. Food and Drug Administration has granted Priority Review to a supplemental Biologics License Application (sBLA) filed by Astellas Pharma Inc. and Pfizer Inc., seeking to expand…
Read More...

Biocon Limited has secured regulatory approval in Canada for two of its denosumab biosimilars, marking a significant expansion of its global biosimilars portfolio. The company announced…
Read More...

Biogen Inc. has entered into a definitive agreement with TJ Biopharma to acquire exclusive rights to the investigational drug felzartamab in the Greater China region, completing its…
Read More...